Moderna Therapeutics is touting results from its first phase of testing for a coronavirus vaccine. But problems are likely to arise once a cure is developed. Politico's health care reporter Sarah Owermohle joins CBSN's Reena Ninan to explain how the Trump administration may have issues with distributing and developing a vaccine.
